1.53 USD
▲+0.01+0.66%
盘后 1.46 0.00%
2026-09-16
市值
$213.53M
市盈率
—
EPS
-5.80
股息率
—
52 周区间
1.27 – 27.36
成交量
41.07K
Beta
0.18
目标价
—
52W 低 1.2752W 高 27.36
价格走势
公司简介
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation....